Vusion Ointment

VUSION^® Ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast) in immunocompetent pediatric patients 4 weeks and older. A positive fungal culture for C albicans is not adequate evidence of candidal infection since colonization with C albicans can result in a positive culture. The presence of candidal infection should be established by microscopic evaluation prior to initiating treatment.

Important Safety Information for prescription VUSION^® Ointment
The safety of VUSION^® Ointment when used for longer than 7 days is not known.

The safety and efficacy of VUSION^® Ointment have not been demonstrated in immunocompromised patients, or in infants less than 4 weeks of age (premature or term).

If irritation occurs, or it the rash worsens, stop treatment and contact your healthcare provider.

For external use only. VUSION^® Ointment is for topical use only, and not for ophthalmic, oral or intravaginal use.

VUSION^® Ointment should not be used as a substitute for frequent diaper changes. VUSION^® Ointment should not be used to prevent the occurrence of diaper dermatitis, since preventative use may result in the development of drug resistance.

Click here for complete Prescribing Information for VUSION^® Ointment

STIEFEL, STIEFEL & Design, VUSION, STIEFELCARE and STIEFEL CARE & Design are registered trademarks of Stiefel Laboratories, Inc.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


VUSION^® Ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast) in immunocompetent pediatric patients 4 weeks and older. A positive fungal culture for C albicans is not adequate evidence of candidal infection since colonization with C albicans can result in a positive culture. The presence of candidal infection should be established by microscopic evaluation prior to initiating treatment. Important Safety Information for prescription VUSION^® Ointment The safety of VUSION^® Ointment when used for longer than 7 days is not known. The safety and efficacy of VUSION^® Ointment have not been demonstrated in immunocompromised patients, or in infants less than 4 weeks of age (premature or term). If irritation occurs, or it the rash worsens, stop treatment and contact your healthcare provider. For external use only. VUSION^® Ointment is for topical use only, and not for ophthalmic, oral or intravaginal use. VUSION^® Ointment should not be used as a substitute for frequent diaper changes. VUSION^® Ointment should not be used to prevent the occurrence of diaper dermatitis, since preventative use may result in the development of drug resistance. Click here for complete Prescribing Information for VUSION^® Ointment STIEFEL, STIEFEL & Design, VUSION, STIEFELCARE and STIEFEL CARE & Design are registered trademarks of Stiefel Laboratories, Inc. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
www.stiefel.com